 |
Beta Casein | Beta Casein
The research behind the health risks associated with A1 beta casein, including diabetes, heart disease and autism and the health benefits and reduced risk of disease linked to A2 beta casein. The bioactives released on digestion from casein include opioid peptides released from A1 beta casein that are linked to increased health risks.
Betacasein.org ~
Site Info
Whois
Trace Route
RBL Check
|
 |
PAINClinician :: Sharing Resources. Exchanging Ideas. Debating Issues for the Pain Treating Community.
PAINClinician™ is an independently funded forum committed to improving clinician access to high quality pain education. PAINClinician™ provides clinicians with an opportunity to share their insights and experience managing patients with debilitating acute and chronic pain disorders. By consolidating resources already available and generating new educational materials tailored to the needs of the community—all identified through ongoing surveys posted throughout the site—this forum will, we believe, facilitate the exchange of ideas, help clinicians practice the art and science of pain medicine, and ultimately improve patient care. Primary care physicians, pain specialists, emergency room clinicians, surgeons, physiatrists, anesthesiologists, neurologists, pharmacists, physician assistants, nurse practitioners, nurses, and the countless other healthcare providers who treat pain are all invited to participate in this global community.
Painclinician.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Molecular Medicine published by The Feinstein Institute for Medical Research
Molecular Medicine is a bimonthly publication which focuses on disease pathogenesis at the molecular level. Molecular Medicine strives to understand normal body functioning and disease patho- genesis at the molecular level which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2009 Journal Citation Report, showing impact factors calculated from citations of articles published in 2008 and 2007, lists Molecular Medicine with an impact factor of 5.020, putting it in the top 6% of publications. Molecular Medicine publishes work in the format of original research articles, review articles, mini-reviews, editorials, and commentaries on emerging concepts in the interdisciplinary field of molecular medicine.
Molmed.org ~
Site Info
Whois
Trace Route
RBL Check
|
|
|
|
Site Info
